Libra Infusions (DHA:LIBRAINFU) NonCurrent Deferred Liabilities: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
21 GF Score
Price BDT640.80
View Full Analysis

What is Libra Infusions NonCurrent Deferred Liabilities?

Libra Infusions DHA:LIBRAINFU -0.48% 21 NonCurrent Deferred Liabilities is BDT0.00 Mil as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 21/100.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Libra Infusions's non-current deferred liabilities for the quarter that ended in . 20 was BDT0.00 Mil.

Libra Infusions NonCurrent Deferred Liabilities Related Terms

Libra Infusions NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Libra Infusions's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions NonCurrent Deferred Liabilities Chart

Libra Infusions Annual Data
Trend
NonCurrent Deferred Liabilities

Libra Infusions Semi-Annual Data
NonCurrent Deferred Liabilities
DHA:LIBRAINFU
21GF Score
Libra Infusions Ltd DHA:LIBRAINFU
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of BDT0.00 Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a NonCurrent Deferred Liabilities of BDT0.00 Mil as of . 20. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' NonCurrent Deferred Liabilities too high?
Libra Infusions' current NonCurrent Deferred Liabilities is BDT0.00 Mil. Overall, Libra Infusions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' NonCurrent Deferred Liabilities compare to SECI and LENSF?
Libra Infusions' NonCurrent Deferred Liabilities of BDT0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Libra Infusions and its competitors. Libra Infusions's current NonCurrent Deferred Liabilities is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current NonCurrent Deferred Liabilities of BDT0.00 Mil. The current NonCurrent Deferred Liabilities is BDT0.00 Mil. Libra Infusions' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current NonCurrent Deferred Liabilities is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
21GF Score

Get the complete analysis for DHA:LIBRAINFU

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT640.80
Price